Global Women’s Health Diagnostics Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Women’s Health Diagnostics Market Research Report 2024
Women’s health diagnostics market is growing due to the increasing prevalence of osteoarthritis, ovarian cancer, breast cancer and cervical cancer.
According to Mr Accuracy reports new survey, global Women’s Health Diagnostics market is projected to reach US$ 43800 million in 2029, increasing from US$ 27230 million in 2022, with the CAGR of 6.9% during the period of 2024 to 2029.
North America dominates the women's health diagnostics market owing to rising adoption of technologically advanced products. Moreover, government initiatives and product launches will further drive the growth of the women’s health diagnostics market in the region over the forecast period. The women's health diagnostics market in Asia Pacific is expected to witness substantial growth owing to improving healthcare infrastructure. In addition, initiatives taken by the government have increased women's participation in the workforce. Moreover, rising awareness about women's health disorders is expected to further drive the growth of the women's health diagnostics market in the region in the coming years.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Women’s Health Diagnostics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Abbott Laboratories
Roche
Philips
Siemens
Perkinelmer Inc.
Alere Inc.
GE Healthcare
Becton, Dickinson and Company
Biomerieux SA
Quest Diagnostics Inc.
Hologic, Inc.
Segment by Type
Diagnostic Devices
Diagnostic Tests
Breast Cancer
Infectious Disease Testing
Osteoporosis Testing
Pregnancy and Fertility Testing
Sexually Transmitted Disease Testing
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Women’s Health Diagnostics report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to Mr Accuracy reports new survey, global Women’s Health Diagnostics market is projected to reach US$ 43800 million in 2029, increasing from US$ 27230 million in 2022, with the CAGR of 6.9% during the period of 2024 to 2029.
North America dominates the women's health diagnostics market owing to rising adoption of technologically advanced products. Moreover, government initiatives and product launches will further drive the growth of the women’s health diagnostics market in the region over the forecast period. The women's health diagnostics market in Asia Pacific is expected to witness substantial growth owing to improving healthcare infrastructure. In addition, initiatives taken by the government have increased women's participation in the workforce. Moreover, rising awareness about women's health disorders is expected to further drive the growth of the women's health diagnostics market in the region in the coming years.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Women’s Health Diagnostics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Abbott Laboratories
Roche
Philips
Siemens
Perkinelmer Inc.
Alere Inc.
GE Healthcare
Becton, Dickinson and Company
Biomerieux SA
Quest Diagnostics Inc.
Hologic, Inc.
Segment by Type
Diagnostic Devices
Diagnostic Tests
Segment by Application
Breast Cancer
Infectious Disease Testing
Osteoporosis Testing
Pregnancy and Fertility Testing
Sexually Transmitted Disease Testing
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Women’s Health Diagnostics report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source